PRAGMATIC APPROACH OF AYURVEDA IN LONG-COVID MANAGEMENT – A CASE STUDY

Authors

  • Pushpa Singh Department of Kaya-Chikitsa, B. R. Harne Ayurvedic College & Research Institute, Karav-Vangani, Maharashtra, India

Keywords:

Long-COVID, Dhatu-Kshaya, Aptarpan, Brimhana, Rasayan.

Abstract

Although most people with COVID-19 get better within weeks of illness, some people experience post-COVID condition. Long-COVID is a post-COVID condition, is also known as Long-Haul-COVID / post COVID syndrome (PCS). It is estimated that 10 – 30% of patients might experience Long-COVID after recovering. It is incredibly frustrating and impacts the health, employment status and overall quality of life. There is a significant interest in medication to treat Long-COVID.  Data about the safety and benefit of medications and supplements is currently insufficient and more research is needed.

According to Ayurveda, LONG COVID can be interpreted as Aptarpanjanya Vikara (disease) caused by Vatapittaprakop, Dhatu-kshaya and Bala-kshaya. Such condition can be treated mainly by Vatapitta Shamak, Brimhana and Resayan Chikitsa.

A 14 years old male patient diagnosed as Long-COVID reported to my OPD with complaints of low grade fever, fatigue, multiple joint pain, muscle pain since 4-months. Also, he experienced worsening of systems after physical or mental activity. He was treated at OPD level with Suvarnamalini Vasant Ras, Drakshadi Kashayam and Guduchisiddha Ghrut.  Abhyanga with Chandanadi Taila was also advised. The treatment over the period of three months resulted in complete relief. Thus the Ayurvedic treatment was found to be effective in managing Long-COVID.

Downloads

Download data is not yet available.

Downloads

Published

2022-04-04

How to Cite

Singh, P. (2022). PRAGMATIC APPROACH OF AYURVEDA IN LONG-COVID MANAGEMENT – A CASE STUDY. Ayurline: International Journal of Research in Indian Medicine, 6(02). Retrieved from https://ayurline.in/index.php/ayurline/article/view/651

Issue

Vol. 6 No. 02 (2022): AYURLINE: IJ-RIM | April- June: 2022

Section

Case Report

License

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.

Please read following declaration cum Agreement Carefully.:

I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.

I (We) agree (on behalf of me and my co-authors) to the following:

1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.

2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.

3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.

4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.

5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).

6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.

8- If I / We found victims of plagiarism, (साहित्यिक चोरी) (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.

7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.  

8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.